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Abstract
Genetic counselling services are well established in North America, Western Europe and Australia. In other regions, genetic 
counselling services are still emerging. Where this is the case, an in-depth understanding of the main stakeholders’ needs, 
challenges and opportunities will inform the changes and innovations required to bring genetic counselling closer to the 
community. The present study explored the needs and challenges of patients, family members and professionals with a 
view to setting up a cancer genetic counselling service in Romania. In order to get a comprehensive outlook, key stakehold-
ers were interviewed using data source triangulation method. Thirty-four semi-structured interviews were conducted (13 
patients, 11 family members and 10 professionals). Thematic analysis was used to explore and identify needs, barriers and 
opportunities in emerging cancer genetic counselling services. Three major themes were identified: (1) the “Needs” theme 
mainly focuses on various types of support that participants mentioned wanting: psychosocial, peer and additional support; 
(2) the “Challenges” theme includes aspects related to limited access to healthcare, lack of integrated services and pressure 
on the families; (3) the “Hopes” theme highlights the wish for integrated healthcare and an empathic rapport with healthcare 
providers. Our findings highlighted the main needs, challenges and hopes the patients, family members and professionals 
have and provides the groundwork for setting up cancer genetic counselling services.
Keywords Cancer genetic counselling · Health communication · Service delivery
Introduction
Genetic counselling is aimed at “helping people understand 
and adapt to the medical, psychological and familial impli-
cations of genetic contributions to disease. This process 
integrates the following: (1) interpretation of family and 
medical history to assess the chance of disease occurrence 
or recurrence; (2) education about inheritance, testing, man-
agement, prevention, resources and research; (3) counselling 
to promote informed choices and adaptation to the risk or 
condition” (Resta et al., 2006). Genetic counselling has 
become an established service in North America, Western 
Europe and Australia and we now have substantial empirical 
evidence supporting its efficacy (Braithwaite, Emery, Walter, 
Prevost, & Sutton, 2004, Meiser & Halliday, 2002; Smerec-
nik, Mesters, Verweij, de Vries, & de Vries, 2009). Although 
access to genetic counselling remains uneven globally, there 
are ongoing efforts and improvements across standards of 
practice, training and regulation (Abacan et al., 2019).
In cancer settings, genetic counselling aims to identify and 
provide support to individuals affected by/at increased risk of 
an inherited predisposition to cancer. Cancer genetic counsel-
ling usually includes (1) taking a detailed personal and famil-
ial medical history, (2) assessment of genetic cancer risk, (3) 
facilitating informed consent for genetic testing, (4) disclosure 
of genetic test results and (5) psychosocial assessment (Riley 
et al., 2012). Cancer genetic counselling often, but not always, 
includes genetic testing. State-of-the art guidelines (e.g., 
National Society of Genetic Counselors and American Soci-
ety of Clinical Oncology) recommend testing when certain 
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conditions are met. These include (1) clinical conditions (e.g., 
a suggestive family history for inherited cancer; the test has 
an influence on medical management for individuals or the 
family) and (2) ethical conditions (e.g., testing is voluntary 
and informed consent is given; benefits of the test outweigh 
the risks; and test results can be adequately interpreted) (Riley 
et al., 2012; Robson,  Storm, Weitzel, Wollins, & Offit, 2010).
Two systematic reviews have shown that cancer genetic 
counselling improves a large variety of outcomes (Athens 
et al., 2017; Madlensky et al., 2017). These include cogni-
tive outcomes (e.g., knowledge, perceived personal control, 
risk perception accuracy and decisional conflict), affective 
outcomes (e.g., anxiety, cancer-related worry, psychologi-
cal wellbeing), behavioural outcomes (e.g., positive health 
behaviours, uptake of genetic testing or screening, medical 
management), and other outcomes such as satisfaction and 
sharing information (Athens et al., 2017; Madlensky et al., 
2017).
Patients in Romania, as in many other countries, have 
limited access to integrated healthcare services and there 
is a disconnection between highly specialized care and pri-
mary or community care (Vlădescu et al., 2016). There is 
an increasing trend to provide integrated and personalized 
healthcare services, however there are several systemic chal-
lenges that need to be addressed. In cancer settings, limited 
funds are available for reimbursement of specialized ser-
vices such as genetic testing, and the National Health Insur-
ance House is planning to improve access to genetic test-
ing in oncology setting (National Health Insurance House, 
2019). National screening programs for cancer are starting 
to develop, with ongoing or pilot programs, but there are 
no national screening programs for several types of can-
cer, including colorectal cancer (Cancer screening in the 
European Union, 2017). Furthermore, national guidelines 
and professional recommendations for psychosocial care in 
cancer settings are essentially lacking (Dégi, 2016). Genetic 
counselling is not yet recognized as a distinct healthcare 
profession even though there are approximately 75 trained 
genetic counsellors in the country (Abacan et al. 2019).
Our main objective was to gain an in-depth perspec-
tive of the needs, barriers and opportunities in the devel-
opment of cancer genetic counselling services with input 




We conducted 34 semi-structured interviews using data 
source triangulation method (Carter et al., 2014) to collect a 
comprehensive set of diverse experiences and to ensure data 
saturation; we interviewed 13 patients, 11 family members 
and 10 healthcare professionals. Purposive sampling was 
used to recruit participants based on their potential need to 
access (i.e., patients and family members) or to recommend 
genetic counselling (i.e., professionals with diverse back-
grounds such as genetic counselling, genetics, oncology, sur-
gery, psychology or social work). Participants were recruited 
from the Oncology Institute in Cluj-Napoca, Romania, and 
several affected individuals from cancer patients’ asso-
ciations. Participants’ characteristics are summarized in 
Tables 1, 2 and 3.
Interviews
The semi-structured interviews were focused on 3 main 
areas: (1) psychological and emotional needs, (2) medi-
cal and healthcare issues, and (3) individual and familial 
aspects. Interview guides are available in the supplementary 
materials. The interviews had a similar structure, with ques-
tions adapted for each category of participants; the profes-
sionals had an additional set of questions explicitly related 
to genetic counselling.
Procedure
Most interviews were conducted face-to-face (by the first 
author) at the hospital or in participants’ workplace, with 
some interviews conducted on the telephone due to con-
venience (e.g., two patients were very keen to participate 
but lived outside the city and had difficulties travelling). 
On average, the interviews had a duration of approximately 
30 min. Interviews were audio-recorded and transcribed 
verbatim. Before the interview, each participant had the 
Table 1  Patients’ characteristics
Patient Gender Age Diagnosis Years 
since diag-
nosis
1 F 64 Chronic myeloid leukemia 10
2 F 38 Chronic myeloid leukemia 14
3 F 50 Chronic myeloid leukemia 13
4 F 72 Breast cancer 2
5 F 64 Breast cancer 10
6 F 52 Breast cancer 1
7 F 56 Breast cancer 1
8 F 52 Breast cancer 1
9 F 49 Colon cancer 3
10 M 43 Testicular cancer 1
11 M 40 Osteosarcoma 1
12 F 61 Breast cancer 1
13 F 63 Breast cancer 1
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opportunity to discuss the study at length and ask ques-
tions; all participants signed an informed consent form. The 
study was approved by the ethics committee of the Oncology 
Institute.
Data analysis
Thematic analysis was used to explore and identify the main 
themes in the interviews. Data analysis followed the proce-
dure described by Braun and Clarke, 2006. In the first phase, 
the interviews were transcribed and observations about the 
data were noted. In the second phase, the interviews were 
coded in an inductive manner in order to extract relevant 
data. This phase was performed using a Microsoft Excel 
software based on the strategy proposed by Bree & Gerry, 
2016. In the third phase, the codes were color coded and 
grouped based on color to facilitate theme searching. In the 
fourth phase, themes and sub-themes were identified, named 
and reviewed, and a thematic map was generated as shown 
in Fig. 1. The final step of the analysis was to select quotes 
that best capture the themes identified, the proposed research 
questions and overarching literature. The last interviews 
taken in each category brought only modest novelty to the 
pool of data already collected suggesting that data saturation 
was reached. This was also supported in the coding phase of 
the analysis when the emergent themes were supported by a 
significant number of codes (Fusch & Ness, 2015).
Results
In total, 34 semi-structured interviews were conducted and 
analyzed. Following the thematic analysis, three major 
themes emerged: (1) Needs; (2) Challenges; (3) Hopes. Due 
to significant overlap and convergent ideas across all three 
categories of participants, the themes and subthemes are 
discussed together.
Needs
The most salient theme across all interviews and catego-
ries of participants was the strong need for support, for both 
patients and families. Understanding the type of support 
patients and families need in cancer setting is essential for a 
functional and meaningful integration of genetic counselling 
services. Three sub-themes emerged here, each one describ-
ing different types of support needed.
Psychosocial support Participants consistently mentioned 
the need to receive (i.e., patients, families) or provide (i.e., 
professionals) psychosocial support throughout the progress 
of their condition. Support is needed when coping with a 
cancer diagnosis and managing subsequent life changes, 
dealing with anxiety related to surgery and response to 
treatment, understanding implications for family members, 
dealing with intense negative emotions as well as the fear 
of being pitied. Patients also discussed needing support in 
Table 2  Family members’ characteristics
Family 
member
Gender Age Affected fam-
ily member
Diagnosis
1 F 32 Parent Kidney cancer
2 F 28 Parent Colon cancer
3 F 28 Aunt Endometrial cancer
4 F 52 Parent Eye cancer
5 M 63 Parent Prostate cancer
6 F 49 Sister Breast cancer
7 M 45 Partner Neck cancer
8 F 44 Parent Prostate cancer
9 F 29 Parent Ovarian cancer
10 M 50 Partner Breast cancer
11 F 25 Parent Breast and uterus cancer
Table 3  Professionals’ 
characteristics
Professional Gender Age Specialty Years of 
experi-
ence
1 F 25 Lab biology (cancer setting) 3
2 F 30 Genetic counseling 8
3 F 27 Genetic counseling 4
4 M 47 Clinical genetics 28
5 F 45 Clinical genetics (cancer setting) 15
6 M 30 Oncology and surgery 5
7 F 30 Social work (cancer setting) 5
8 F 32 Clinical psychology (cancer setting) 7
9 M 32 Clinical genetics (cancer stetting) 12
10 F 55 Patient organization 7
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managing the impact of the disease on family and couple 
relationships. Family members emphasized the need for a 
setting to discuss their own questions, concerns, or grief. 
Emotional and psychological support was most often seen 
in close connection with the medical care. Both patients 
and family members highlighted how struggling with nega-
tive emotions can interfere with understanding the medi-
cal information or adhering to treatment. Although there 
is clear consensus about the need for psychosocial support, 
professionals noted a reluctance of many patients to access 
psychological support services, mainly due to misconcep-
tions or fear of being stigmatized for seeing a “mental health 
specialist”.
"Maybe it would help to see a psychologist, or something. 
When you’re sitting here, in the hospital, there are times 
when you are on the ropes. You know, like in boxing, when 
you just can’t take it anymore. And sometimes doctors need 
to understand that. I have experienced it myself […]. Yes, 
emotionally… it’s hard." (Patient).
Peer support Participants identified their peers and com-
munity as a valuable source of support. Patients often men-
tioned that they benefited from attending various support 
groups and family members said they would attend support 
groups themselves if they would find one tailored to their 
needs. Patients associations were described as “rescue life-
lines” and several patients said they benefited from attending 
different meetings and conferences. Awareness campaigns 
for different types of cancer were described as being empow-
ering. Some participants also acknowledged the value of 
fundraising campaigns either for individual cases or spe-
cific services, such as genetic testing. Maintaining an active 
professional life and connecting with work colleagues was 
also described as a valuable source of support. Profession-
als also discussed the benefits of peer support, or attending 
conferences; collaboration was mentioned particularly in the 
context of working or wanting to work in a multidisciplinary 
team. Several patients mentioned their desire to “give back” 
and share some of their experience, hoping that it might help 
others dealing with similar difficulties.
"If you have people around you, if you have nice people 
in your hospital room… […], we go in the hospital park and 
we discuss a lot. I saw a lot of exhausted people and I said 
“C’mon people, why do you victimize yourselves so much? 
We are all here without various parts of our bodies because 
this is it… we all have these problems and we are all sur-
viving, and we can be grateful for that.” And do you know 
what? After chats like that people started looking for us, for 
our room, because they felt that our group was emanating, 
how can I put it, health… and it helped them forget about 
the negative stuff." (Patient).
Additional support Another sub-theme we identified was 
a distinct need for additional sources of support, in order 
to cope with long-term consequences and lifestyle changes 
following a cancer diagnosis. Some patients mentioned par-
ticipating in research studies or their desire to do so. Some 
described using alternative medicine to help them cope with 
the side effects of the medical treatment. Several patients 
mentioned a specific need for “administrative” support, such 
as help to navigate medical services that are not reimbursed 
by the national insurance, their rights and available options, 
accessibility or just plain guidance in the hospital. Overall, 
most patients described an underlying need to focus more 
on their quality-of-life and enhance their personal autonomy. 
Spirituality and pastoral care were other essential sources of 
support for many participants. Patients and families consist-
ently described the value of faith in coping with the diagno-
sis and some of them suggested religious groups could get 
involved in patient care.
Fig. 1  The thematic map
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"Pff … Now I do not want to be that godly (laughs), but I 
think God has to help us. First of all, we need to have faith, 
trust… I don’t know how to tell you … Faith in God and trust 
in the doctors. Without doctors, there is nothing we can do, 
even if we pray." (Patient).
Challenges
Early in the course of the interviews it became clear that 
the overarching context of the healthcare system will be 
essential in understanding the needs and challenges of the 
stakeholders involved. The three sub-themes that emerged 
here are detailed below.
Limited access to healthcare This sub-theme highlights 
the difficulties some cancer families and professionals 
face with the national healthcare system. Whilst this may 
not be a challenge for individuals living in urban areas or 
with straightforward access to public or private hospitals, a 
number of individuals continue to struggle with access to 
adequate care. One of the most frequently mentioned chal-
lenges is the difficulty to access medical services due to long 
waiting lists, travelling arrangements, overcrowded hospi-
tals and reduced number of staff. Some patients and family 
members also disapproved the paternalistic attitude some 
of the medical doctors continue to have. Regardless of the 
difficulties mentioned, patients and families expressed their 
empathy and gratitude towards the staff, and tried to remain 
hopeful for the future.
"I think the hospital is too small for everybody coming 
here. The staff is not enough, they simply can’t cope. I think 
they are completely exhausted. Starting from the bottom and 
all the way up to the top. It’s too much, on everyone. I had a 
close look yesterday, when I came for my radiotherapy ses-
sion, there were 687 admissions to the hospital. Just think 
about how many people are here!" (Patient).
Lack of integrated care This sub-theme highlighted the fact 
that integrated care for cancer patients is essentially lacking 
and there is a strong need to access (i.e., patients, family 
members) and provide (i.e., professionals) comprehensive, 
personalized care. The importance of multidisciplinary 
teams and the benefits of a good collaborative relationship 
between professionals and families were also highlighted. 
GPs were seen as having an essential connecting role within 
the team. Professionals also suggested the need for a tight 
collaboration between oncologists, surgeons, radiologists, 
nurses, geneticists, psychologists and genetic counsellors. 
The need for coherent, patient-centered public polices and 
good practice guidelines were also strongly emphasized.
"There are difficulties when it comes to accessing ‘other’ 
services, like other than your own. There are no integrated 
services. So that’s the big problem! When it comes to 
genetics, you really feel it… I guess for other specialties 
too… "(Professional).
"I think the treatment would be more successful [In mul-
tidisciplinary settings]. Let me give you an example: in my 
experience, the patients I am seeing as part of a team have 
better outcomes than patients seen by myself or my col-
leagues alone. Individually we might miss something but as 
a team, we are better." (Professional).
Pressure for the family Family members of individuals 
diagnosed with cancer face a number of challenges them-
selves. They act as advocates and information facilitators 
for the patient and, when the healthcare pathways are not 
straightforward, they often initiate the contact with various 
professionals and take initiative in “organizing” the care for 
their loved ones. Many family members also discussed the 
difficulties obtaining and understanding the medical infor-
mation themselves. Often, they described their role as trying 
to persuade the affected individual to adhere to treatment 
or convincing other family members to undergo screening, 
without having a clear understanding of the implications that 
particular cancer diagnosis can have for the wider family.
"The expectations from my family were very high… I had 
to support him [my dad] with everything, help with doctor 
appointments and what not. I am coming [at the hospital] 
almost every day. He needed me to stay overnight after sur-
gery, he was confused for a few days and risked getting out 
of bed as he probably did not know where he was. You know, 
anesthesia and a bunch of other factors… age maybe. And 
I stayed every day and every night when it was necessary. 
Now I come to bring him comfort." (Family member).
Hopes
The third theme encompasses the transformational impact 
of health communication and personalized approach. Across 
most interviews, participants shared their experience with 
health information in general and genetics in particular. Par-
ticipants touched upon hope, mainly as a result of health 
communication; patients discussed feeling hopeless after 
getting information from unreliable sources and in a few 
instances, professionals discussed how health communica-
tion can instill hope. Two sub-themes are included here.
Integrated healthcare Most participants mentioned the idea 
of a more personalized approach to their care, particularly in 
complex situations where a cancer family history is present. 
The need to better understand symptoms, causes, treatment 
options, risk factors for themselves or others, and screening 
options were mentioned repeatedly. Participants hoped for 
an easier and more integrated access to genetic counselling 
services. Interestingly, and unexpectedly, patients and fam-
ily members often described genetic counselling without 
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actually naming it, ideally facilitated by a trained profes-
sional, in a dedicated type of appointment.
"I’d like to see changes in terms of communication, but I 
also understand that the doctors don’t have time to commu-
nicate, you know? I mean, they do their job in a very profes-
sional way. But there is no professional that has in the job 
description only this task, to communicate to the patient and 
the family how things are. And then you get this feeling of 
insecurity because you feel somehow misinformed, but it is 
not out of bad will, but out of the stiffness of the health care 
system. It is very difficult and inefficient. But if there was a 
way around this… I am talking about another kind of profes-
sional here… like in other areas, you have some kind of a 
spokesperson or something, you know?" (Family member).
Patients and family members were generally aware when 
a history of cancer was present in the family and, in several 
instances, they questioned the inheritance pattern or the idea 
that cancer was in fact inherited. During the interviews, sev-
eral myths related to the causes, genetics or inheritance of 
cancer became apparent such as inheritance only by males/
females in the family. In one instance a patient described her 
surprise to find out that her adolescent son had an appoint-
ment with the GP to discuss his mother’s diagnosis and to 
understand more about his risks. In other instances, family 
members described increasing the frequency of screening 
or attending screening for the first time following a can-
cer diagnosis in the family, even if the additional care was 
not formally recommended by a doctor. Family members 
also described their difficulties in communicating sensitive 
medical information with the wider family or difficulties 
in obtaining informed consent for genetic testing. In this 
context, patients also discussed ethical aspects surrounding 
genetic testing such as “duty to warn” as a reason for test-
ing and professionals mentioned difficult situations where 
they were asked to offer genetic testing to children and 
adolescents.
Professionals were clearly aware of genetic counselling 
and explicitly addressed it. Most of them mentioned the low 
awareness of genetic counselling and the unsystematic man-
ner in which it continues to be offered to patients and fami-
lies. Genetic counselling was described as having numerous 
benefits such as facilitating adaptation to cancer, under-
standing and managing risks, discussing the implications of 
genetic testing, facilitating decisions related to genetic test-
ing or prophylactic interventions and providing emotional 
support throughout the entire process. Professionals, espe-
cially the clinicians and in some cases lab professionals, saw 
genetic counselling as a partial delegation of their own tasks 
(e.g., providing information and support), or a continuation 
of their role, beyond their expertise (e.g., discussing genetic 
testing in the case of oncologists). Genetic counselling was 
also described as a way to maintain hope and resilience in 
affected families.
Whilst most professionals stressed the need for genetic 
counselling, they also discussed several barriers in setting 
up this service, such as trained specialists, willingness to 
incorporate the logistics of a new service, insufficient fund-
ing of genetics and genetic testing, and the lack of a systemic 
interdisciplinary mindset. Some professionals proposed 
ways to address some of these challenges, such as training 
professionals to provide a basic level of genetic counsel-
ling only for conditions in their specialty (e.g., oncology, 
gynecology).
"Often, it’s not the specialists who refers the patients [to 
genetic counselling], they come on their own – they might 
have seen a brochure, or they found out about us from the 
social media and so on. Other times they are indeed referred 
by the doctors but, honestly, let me tell you, it’s the same 
doctors every time. There are some who are so open and 
others who are probably totally uninterested or uninformed, 
I don’t know." (Professional).
Empathic rapport This sub-theme is mainly focused on 
patients’ wish for a more “humane” interaction with the 
professionals and a more personalized communication 
throughout their care journey. The majority of participants 
described a great need for simple, plain language when dis-
cussing medical information. Some suggested professionals 
could use metaphors, visual aids or leaflets written in plain 
language to facilitate establishing a personal rapport. Many 
of the interviewed patients and family members suggested 
some professionals could benefit from additional training 
in communication. Using plain language was described as 
likely to increase the adherence to treatment, to improve the 
doctor-patient relationship and to help coping with cancer 
management, in general.
"I think it would be important to have at least one genetic 
counsellor in every genetics department. At least one… if not 
an army of them! To have them talk to patients because they 
need someone who speaks their language, who empathizes 
with them, to really feel that empathy. And be a little bit 
more… more available than doctors. Not that doctors are not 
available but I think they would also really need a genetic 
counsellor." (Professional).
In their quest to understand the diagnosis, with everything 
it encompasses, the majority of the patients and family mem-
bers said they tend to research medical information using 
various internet resources, and they almost always verify it 
with the medical team. Professionals often saw this as prob-
lematic due to misconceptions and truncated information 
they often have to subsequently address. Clearly, sharing 
the same language or narrative can enable a good rapport 
between professionals and families; equally, communication 
glitches can impact this relationship. Having said that, none 
of the professionals mentioned language or communication, 
either as a concern, challenge or a priority in particular.
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"The information I received was a bit too detailed, 
because I didn’t understand everything they were saying. I 
told him I didn’t understand and then he tried to explain it 
to me again. I don’t know, I guess he was very tired after the 
surgery, I don’t know… he was telling me words he knew, 
but I told him that I didn’t understand them… to take it a 
bit slowly because I had no idea what he was talking about. 
Also, I was incredibly nervous after the surgery. I guess I 
just wanted to talk a bit more in my own language, if pos-
sible." (Family member).
Discussion
Our study was aimed at exploring the needs and challenges 
of patients, family members and professionals working 
in cancer settings, in a healthcare system where genetic 
counselling is not typically offered. We also wanted to see 
whether and to what extent genetic counselling is available 
or recommended. The findings uncovered key aspects of 
the current clinical practice in cancer settings, highlight-
ing pressing needs and challenges amongst the interviewed 
stakeholders, as well as hopes and opportunities to bring 
genetic counselling services closer to the community.
The most prominent theme across all interviews and cat-
egories of participants was the need for support, for both 
patients and families. Patients and families were generally 
aware of a family history of cancer and often expressed con-
cerns over adequately understanding the implications it had 
for their own diagnosis or the risks of other family mem-
bers. Our findings also suggest that even some healthcare 
professionals may have difficulties assessing or interpreting 
a family history of cancer. In the relatively rare instances 
where professionals discuss hereditary cancers, most often 
they appear to concentrate on providing information, assess-
ing risks, discussing screening or recommending testing. 
All three categories of participants discussed aspects sur-
rounding informed consent, autonomy and confidentiality 
regarding genetic testing or other medical procedures. Sev-
eral participants went on to discuss ethical concerns such 
as testing of children, equitable access to testing and the 
“duty to warn” family members about cancer risk. The wish 
to establish an empathic rapport, the value of personalized 
communication, and the interest and awareness for an ethical 
practice are all very much in line with the ethos of genetic 
counselling—facilitating and supporting patients’ autonomy 
and informed decisions.
The main challenges identified by most participants were 
limited access to healthcare and low availability of inte-
grated care in cancer clinical settings. Patients and families 
mentioned having to access fragmented healthcare services 
which they have to navigate without much support. Most 
professionals echoed this challenge and tried to provide 
explanations or think of solutions. There was a clear consen-
sus, and very much in line with the literature, that multidis-
ciplinary team systems can address fragmentation because 
they promote good relationships and effective communica-
tion with team members, and include into decision-making 
processes patients’ choices, views and psychosocial factors 
(Soukup et al., 2018).
One particularly interesting finding was that most par-
ticipants either clearly indicated or tentatively described the 
need to access genetic counselling services. Often, patients 
and family members described specific aspects of the genetic 
counselling process, without necessarily articulating how the 
service would look like or who the professional delivering 
that service should be. Although a large part of the recruited 
participants was unlikely to have a hereditary diagnosis, we 
systematically witnessed during the interviews myths and 
worries related to genetics and inheritance. Clarifying these 
myths and providing psychological support to individuals 
with increased anxiety related to cancer is an essential part 
of the genetic counselling process. That said, a potential bias 
of the sample included needs to be acknowledged.
There is substantial empirical evidence available to sup-
port the benefits of cancer genetic counselling, either when 
assessing it as a standalone service or when looking at sepa-
rate components of the genetic counselling process, as our 
participants intuitively did. Discussing the family history can 
result in better healthcare outcomes, such as better screen-
ing attendance (Laiyemo et al., 2015) or uptake of cancer 
preventive measures (Metcalfe et al., 2008; van der Aa et al., 
2015). Having a good understanding of cancer is has been 
shown to facilitate informed decisions (Martínez-Alonso 
et al., 2017). Receiving risk assessments has been positively 
associated with higher rates of screening for cancer (Rees 
et al., 2008). Having an appropriate understanding of genetic 
test results has been shown to be essential in facilitating a 
better adaptation to the diagnosis (Giri et al., 2018; Ersig 
et al., 2011; Taber et al., 2015). Genetic counselling can also 
effectively address misunderstandings regarding genetic test-
ing (Borry et al., 2007) and facilitate family communication 
(Chivers Seymour et al., 2010).
When setting up a new service such as genetic counsel-
ling, in addition to advocating for the benefits it has been 
shown to have internationally and could have for other 
patients and families as well, one has to simultaneously 
acknowledge the local systemic difficulties and opportuni-
ties. Setting up a genetic counselling service in a developing 
healthcare system combined with the rapid developments in 
genetics and precision medicine can provide the opportunity 
to design and implement well thought service delivery mod-
els for genetic counselling (Stoll et al., 2018).
Our approach had a bottom-up perspective, aiming to 
identify the needs and perceived barriers of service users and 
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providers, with a view to set up cancer genetic counselling 
services. Further research could collect complementary data 
from other stakeholders in order to better inform the param-
eters of new services, currently emerging but soon needing 
to be formally established. Clearly, policy and decision mak-
ers may have a different perspective; also, their input would 
likely have a broader viewpoint and that would undoubtedly 
bring a valuable input. Our findings could also be comple-
mented with additional data from small towns or rural clin-
ics, as regional experiences and views can significantly differ 
from large university hospitals.
The context of this study enables us to learn how genetic 
counselling services could be best tailored in order to 
address the challenges of a developing healthcare system. 
Locally, our study provides groundwork research for a more 
systematic approach aimed at integrating genetic counsel-
ling in clinical cancer settings. In the light of our results, a 
successful cancer genetic counselling service should actively 
seize the challenges and opportunities in the healthcare sys-
tem to build an interdisciplinary and highly innovative ser-
vice whilst being grounded in the local reality.
To conclude, our study explored the perceived barriers 
and opportunities of the main stakeholders in cancer settings 
in Romania, with a view to establishing a cancer genetic 
counselling service. Our findings highlighted the main 
needs, challenges and hopes the patients, family members 
and professionals have. Patients and family members men-
tioned needing genetic counselling services without actually 
naming them explicitly or even being aware that this type of 
service could in fact be available. Professionals, on the other 
hand, were very explicit about the need to integrate genetic 
counselling in the mainstream care for cancer patients. 
Whilst there are clearly many barriers when trying to set up 
a new service such as genetic counselling, particularly in a 
developing healthcare system, the often-unexpected oppor-
tunities to design and implement well adapted services are 
often easy to miss yet are undoubtedly paramount.
Acknowledgements We are grateful to everyone who agreed to be 
interviewed; patients, family members and professionals who kindly 
and openly discussed sometimes difficult and challenging personal and 
professional experiences. This research would have not been possible 
without their contribution. We are also thankful to Mădălina Filip for 
transcribing and assisting us in organizing the interviews.
Declarations 
Ethics approval and consent to participate All procedures performed 
in studies involving human participants were in accordance with the 
ethical standards of the institutional research committee and with the 
1964 Helsinki declaration and its later amendments or comparable ethi-
cal standards.
Informed consent was obtained from all individual participants in-
cluded in the study.
Conflict of interest Andrada Ciucă, Ramona Moldovan, and Adriana 
Băban declare that they have no conflict of interest.
Open Access This article is licensed under a Creative Commons Attri-
bution 4.0 International License, which permits use, sharing, adapta-
tion, distribution and reproduction in any medium or format, as long 
as you give appropriate credit to the original author(s) and the source, 
provide a link to the Creative Commons licence, and indicate if changes 
were made. The images or other third party material in this article are 
included in the article's Creative Commons licence, unless indicated 
otherwise in a credit line to the material. If material is not included in 
the article's Creative Commons licence and your intended use is not 
permitted by statutory regulation or exceeds the permitted use, you will 
need to obtain permission directly from the copyright holder. To view a 
copy of this licence, visit http:// creat iveco mmons. org/ licen ses/ by/4. 0/.
References
Abacan, M., Alsubaie, L., Barlow-Stewart, K., Caanen, B., Cordier, C., 
Courtney, E., ... & Guan, Y. (2019). The global state of the genetic 
counselling profession. European Journal of Human Genet-
ics,27(2):183-197. https:// doi. org/ 10. 1038/ s41431- 018- 0252-x
Athens BA, Caldwell SL, Umstead KL, Connors PD, Brenna E, 
Biesecker BB (2017) A systematic review of randomized con-
trolled trials to assess outcomes of genetic counselling. Journal 
of Genetic Counselling 26(5):902–933
Borry P, Stultiëns L, Nys H, Dierickx K (2007) Attitudes towards pre-
dictive genetic testing in minors for familial breast cancer: a sys-
tematic review. Crit Rev Oncol Hematol 64(3):173–181. https:// 
doi. org/ 10. 1016/j. critr evonc. 2007. 04. 006
Braithwaite, D., Emery, J., Walter, F., Prevost, A. T., & Sutton, S. 
(2004). Psychological Impact of Genetic Counseling for Familial 
Cancer: A Systematic Review and Meta-analysis. JNCI Journal 
of the National Cancer Institute, 96(2), 122–133. https:// doi. org/ 
10. 1093/ jnci/ djh017
Bree, R. T., & Gallagher, G. (2016). Using Microsoft Excel to code 
and thematically analyse qualitative data: a simple, cost-effective 
approach. All Ireland Journal of Higher Education, 8(2). Retrieved 
from https:// ojs. aishe. org/ index. php/ aishe-j/ artic le/ view/ 281
Braun B, Clarke V (2006) Using thematic analysis in psychology. Qual 
Res Psychol 3(2):77–101. https:// doi. org/ 10. 1191/ 14780 88706 
qp063 oa
Carter N, Bryant-Lukosius D, DiCenso A, Blythe J, Neville AJ (2014) 
The use of triangulation in qualitative research. Oncol Nurs Forum 
41(5):545–547. https:// doi. org/ 10. 1188/ 14. onf. 545- 547
Chivers Seymour K, Addington-Hall J, Lucassen AM, Foster CL 
(2010) What facilitates or impedes family communication fol-
lowing genetic testing for cancer risk? A systematic review 
and meta-synthesis of primary qualitative research. Journal of 
Genetic Counselling 19(4):330–342. https:// doi. org/ 10. 1007/ 
s10897- 010- 9296-y
Cortis LJ, Ward PR, McKinnon RA, Koczwara B (2017) Integrated 
care in cancer: what is it, how is it used and where are the gaps? 
A textual narrative literature synthesis. Eur J Cancer Care 
26(4):e12689
Dégi, C. L. (2016). Psychosocial oncology needs: an absent voice in 
Romania. Debrecen, Hungary: Debrecen University Press
Ersig AL, Hadley DW, Koehly LM (2011) Understanding patterns of 
health communication in families at risk for hereditary nonpoly-
posis colorectal cancer: examining the effect of conclusive versus 
indeterminate genetic test results. Health Commun 26(7):587–
594. https:// doi. org/ 10. 1080/ 10410 236. 2011. 558338
546 Journal of Community Genetics (2021) 12:539–548
1 3
European Commission. (2017). Cancer screening in the European 
Union. Report on the implementation of the Council Recommen-
dation on cancer screening (second report). Retrieved from https://
ec.europa.eu/health/sites/default/files/major_chronic_diseases/
docs/2017_cancerscreening_2ndreportimplementation_en.pdf
Febbraro, T., Robison, K., Wilbur, J. S., Laprise, J., Bregar, A., 
Lopes, V., ... & Stuckey, A. (2015). Adherence patterns to 
National Comprehensive Cancer Network (NCCN) guidelines 
for referral to cancer genetic professionals. Gynecologic oncol-
ogy, 138(1), 109-114
Fusch, P. I., & Ness, L. R. (2015). Are We There Yet? Data Satu-
ration in Qualitative Research. The Qualitative Report, 20(9), 
1408-1416. https://doi.org/10.46743/2160-3715/2015.2281
Giri VN, Obeid E, Hegarty SE, Gross L, Bealin L, Hyatt C … 
Leader A (2018) Understanding of multigene test results 
among males undergoing germline testing for inherited pros-
tate cancer: implications for genetic counselling.&nbsp;The 
Prostate,&nbsp;78(12), 879–888. https:// doi. org/ 10. 1002/ pros. 
23535
Hampel H, Bennett RL, Buchanan A, Pearlman R, Wiesner GL 
(2015) A practice guideline from the American College of 
Medical Genetics and Genomics and the National Society of 
Genetic Counselors: referral indications for cancer predisposi-
tion assessment. Genet Med 17(1):70
Hoskins PJ, Gotlieb WH (2017) Missed therapeutic and prevention 
opportunities in women with BRCA‐mutated epithelial ovarian 
cancer and their families due to low referral rates for genetic 
counselling and BRCA testing: a review of the literature. CA 
Cancer J Clin 67(6):493–506
Khan, A. I., Arthurs, E., Gradin, S., MacKinnon, M., Sussman, J., 
& Kukreti, V. (2017). Integrated Care Planning for Cancer 
Patients: A Scoping Review. International Journal of Integrated 
Care, 17(6). https://doi.org/10.5334/ijic.2543
Krakow M, Ratcliff CL, Hesse BW, Greenberg-Worisek AJ (2017) 
Assessing genetic literacy awareness and knowledge gaps in the 
US population: results from the Health Information National 
Trends Survey. Public Health Genomics 20(6):343–348. https:// 
doi. org/ 10. 1159/ 00048 9117
Laiyemo AO, Thompson N, Williams CD, Idowu KA, Bull-Henry 
K, Sherif ZA, … Smoot DT (2015) Race and colorectal can-
cer screening compliance among persons with a family his-
tory of cancer.&nbsp;World Journal of Gastrointestinal 
Endoscopy,&nbsp;7(18), 1300–1305. https:// doi. org/ 10. 4253/ 
wjge. v7. i18. 1300
Lea DH, Kaphingst KA, Bowen D, Lipkus I, Hadley DW (2011) 
Communicating genetic and genomic information: health lit-
eracy and numeracy considerations. Public Health Genomics 
14(4–5):279–289. https:// doi. org/ 10. 1159/ 00029 4191
Lim JNW, Hewison J (2014) Do people really know what makes a 
family history of cancer? Health Expectations : an International 
Journal of Public Participation in Health Care and Health Pol-
icy 17(6):818–825. https:// doi. org/ 10. 1111/j. 1369- 7625. 2012. 
00808.x
Madlensky L, Trepanier AM, Cragun D, Lerner B, Shannon KM, 
Zierhut H (2017) A rapid systematic review of outcomes stud-
ies in genetic counselling. Journal of Genetic Counselling 
26(3):361–378
Martínez-Alonso, M., Carles-Lavila, M., Pérez-Lacasta, M. J., Pons-
Rodríguez, A., Garcia, M., Rué, M., & InforMa Group (2017) 
Assessment of the effects of decision aids about breast cancer 
screening: a systematic review and meta-analysis. BMJ Open 
7(10):e016894. https:// doi. org/ 10. 1136/ bmjop en- 2017- 016894
McPherson E, Zaleski C, Benishek K, McCarty CA, Giampi-
etro PF, Reynolds K, Rasmussen K (2008) Clinical genetics 
provider real-time workflow study. Genetics in Medicine : 
Official Journal of the American College of Medical Genetics 
10(9):699–706. https:// doi. org/ 10. 1097/ gim. 0b013 e3181 82206f
Meiser, B., & Halliday, J. L. (2002). What is the impact of genetic 
counselling in women at increased risk of developing heredi-
tary breast cancer? A meta-analytic review. Social Science & 
Medicine, 54(10), 1463–1470. https:// doi. org/ 10. 1016/ s0277- 
9536(01) 00133-2
Mendes Á, Paneque M, Sousa L (2012) Are family-oriented inter-
ventions in Portuguese genetics services a remote possibility? 
Professionals’ views on a multifamily intervention for cancer 
susceptibility families. J Community Genet 3(4):311–318. 
https:// doi. org/ 10. 1007/ s12687- 012- 0079-z
Metcalfe, K. A., Foulkes, W. D., Kim-Sing, C., Ainsworth P, 
Rosen B, Armel S … Narod SA (2008) Family history as 
a predictor of uptake of cancer preventive procedures by 
women with a BRCA1 or BRCA2 mutation.&nbsp;Clinical 
Genetics,&nbsp;73(5), 474–479. https:// doi. org/ 10. 1111/j. 1399- 
0004. 2008. 00988.x
National Health Insurance House. (2019). Programul naţional de 
oncologie. Retrieved from http://www.casan.ro/page/programul-
national-de-oncologie.html
Offit K, Thom P (2010) Ethicolegal aspects of cancer genet-
ics. Cancer Treat Res 155:1–14. https:// doi. org/ 10. 1007/ 
978-1- 4419- 6033-7_1
Paneque M, Serra-Juhé C, Pestoff R, Cordier C, Silva J, Moldovan 
R, Ingvoldstad C (2017) Complementarity between medical 
geneticists and genetic counsellors: its added value in genetic 
services in Europe. Eur J Hum Genet 25(8):918
Patch C, Middleton A (2018) Genetic counselling in the era of 
genomic medicine. Br Med Bull 126(1):27–36
Pestoff R, Moldovan R, Cordier C, Serra-Juhé C, Paneque M, Ing-
voldstad CM (2018) How practical experiences, educational 
routes and multidisciplinary teams influence genetic counselors’ 
clinical practice in Europe. Clin Genet 93(4):891–898
Rees G, Martin PR, Macrae FA (2008) Screening participation in 
individuals with a family history of colorectal cancer: a review. 
Eur J Cancer Care 17(3):221–232. https:// doi. org/ 10. 1111/j. 
1365- 2354. 2007. 00834.x
Resta R, Biesecker BB, Bennett RL, Blum S, Estabrooks Hahn S, 
Strecker MN, Williams JL (2006) A new definition of genetic 
counselling: National Society of Genetic Counselors’ task force 
report. Journal of Genetic Counselling 15(2):77–83
Ricci MT, Sciallero S, Mammoliti S, Gismondi V, Franiuk M, Bru-
zzi P, Varesco L (2015) Referral of ovarian cancer patients for 
genetic counselling by oncologists: need for improvement. Pub-
lic Health Genomics 18(4):225–232
Riley BD, Culver JO, Skrzynia C, Senter LA, Peters JA, Costalas JW 
... McKinnon WC (2012) Essential elements of genetic cancer 
risk assessment, counselling, and testing: updated recommenda-
tions of the National Society of Genetic Counselors. Journal of 
genetic counselling, 21(2), 151-161
Robson, M. E., Storm, C. D., Weitzel, J., Wollins, D. S., & Offit, K. 
(2010). American Society of Clinical Oncology Policy State-
ment Update: Genetic and Genomic Testing for Cancer Suscep-
tibility. Journal of Clinical Oncology, 28(5), 893–901. https:// 
doi. org/ 10. 1200/ jco. 2009. 27. 0660
Rodas-Pérez C, Clarke A, Powell J, Thorogood M (2015) Challenges 
for providing genetic counselling in Colombian genetic clin-
ics: the viewpoint of the physicians providing genetic consul-
tations. J Community Genet 6(3):301–311. https:// doi. org/ 10. 
1007/ s12687- 015- 0237-1
Sanghavi K, Moses I, Moses D, Gordon A, Chyr L, Bodurtha J (2018) 
Family health history and genetic services—the East Baltimore 
community stakeholder interview project. J Community Genet 
10(2):219–227. https:// doi. org/ 10. 1007/ s12687- 018- 0379-z
547Journal of Community Genetics (2021) 12:539–548
1 3
Seven M, Bağcivan G, Akyuz A, Bölükbaş F (2018) Women with 
family history of breast cancer: how much are they aware of 
their risk? Journal of Cancer Education : the Official Journal of 
the American Association for Cancer Education 33(4):915–921. 
https:// doi. org/ 10. 1007/ s13187- 017- 1226-3
Skirton H, Lewis C, Kent A, Kosztolanyi G, Goetz P, Hodgson 
S, Kucinskas V, Ozcelik T, Cornel M, Soller M, Coviello D. 
(2007). Core competences in genetics for health professionals 
in Europe Core competences for health professionals who are 
specialists in genetics. Retrieved from https:// www. ebmg. eu/ 
filea dmin/ GCGN_ Downl oads/ Forms/ CoreC ompet enceG eneti 
cSpec ialis ts. pdf
Smerecnik, C. M. R., Mesters, I., Verweij, E., de Vries, N. K., & 
de Vries, H. (2009). A Systematic Review of the Impact of 
Genetic Counseling on Risk Perception Accuracy. Journal of 
Genetic Counseling, 18(3), 217–228. https:// doi. org/ 10. 1007/ 
s10897- 008- 9210-z
Soukup T, Lamb BW, Arora S, Darzi A, Sevdalis N, Green JS (2018) 
Successful strategies in implementing a multidisciplinary team 
working in the care of patients with cancer: an overview and syn-
thesis of the available literature. J Multidiscip Healthc 11:49
Stoll K, Kubendran S, Cohen SA (2018) The past, present and future 
of service delivery in genetic counselling: keeping up in the era 
of precision medicine. Am J Med Genet C Semin Med Genet 
178(1):24–37. https:// doi. org/ 10. 1002/ ajmg.c. 31602
Taber JM, Chang CQ, Lam TK, Gillanders EM, Hamilton JG, Schully 
SD (2015) Prevalence and correlates of receiving and shar-
ing high-penetrance cancer genetic test results: findings from 
the Health Information National Trends Survey. Public Health 
Genomics 18(2):67–77. https:// doi. org/ 10. 1159/ 00036 8745
van der Aa JE, Hoogendam JP, Butter ESF, Ausems MGEM, Verheijen 
RHM, Zweemer RP (2015) The effect of personal medical his-
tory and family history of cancer on the uptake of risk-reducing 
salpingo-oophorectomy. Fam Cancer 14(4):539–544. https:// doi. 
org/ 10. 1007/ s10689- 015- 9827-7
Vig HS, Wang C (2012) The evolution of personalized cancer genetic 
counselling in the era of personalized medicine. Fam Cancer 
11(3):539–544
Vlãdescu C, Scîntee SG, Olsavszky V, Hernández-Quevedo C, Sagan 
A (2016) Romania: health system review. Health Syst Transit 
18(4):1–170
Publisher’s note Springer Nature remains neutral with regard to 
jurisdictional claims in published maps and institutional affiliations.
548 Journal of Community Genetics (2021) 12:539–548
